Proteomics profiling and cytotoxic effect of Curcuma longa on prostate cancer

Open Proteomics Journal

Volumn 4, Issue 1, 2011, Pages 1-11

  Rao, Kurapati V K ^a   Boukli, Nawal M ^b   Samikkannu, Thangavel ^a   Cubano, Luis A ^b   Dakshayani, Babu K ^a   Nair, Madhavan P N ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b Universidad Central del Caribe School of Medicine   (Puerto Rico)

Author keywords

2 DE; Curcuma longa; Curcuminoids; Ethyl acetate fraction; LC MS MS sequencing; Proteomics

Indexed keywords

ACETIC ACID ETHYL ESTER; ACTIN CYTOPLASMIC PROTEIN; ALPHA ACTIN; ANTINEOPLASTIC AGENT; AORTIC ALPHA ACTIN; CALRETICULIN; CELL PROTEIN; CURCUMA LONGA EXTRACT; CYTOPLASM PROTEIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; ELONGATION FACTOR 2; GLUCOSE REGULATED PROTEIN 78; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE OMEGA 1; LAMIN A; LAMIN C; LIPOCORTIN 2; NUCLEOPLASMIN; OXOACID; PARVALBUMIN ALPHA; PHOSPHOPROTEIN; PHOSPHOPROTEIN 1; PROTEIN DISULFIDE ISOMERASE; PROTEIN PRECURSOR; PROTEIN SET; SUCCINYL COENZYME A; UNCLASSIFIED DRUG; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL FUNCTION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CURCUMA LONGA; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG SCREENING; DRY POWDER; ENDOPLASMIC RETICULUM STRESS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METASTASIS POTENTIAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTITION CHROMATOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEOMICS; RHIZOME; TWO DIMENSIONAL GEL ELECTROPHORESIS; ULTRAVIOLET RADIATION; UPREGULATION;

CURCUMA LONGA;

EID: 80053557888     PISSN: None     EISSN: 18750397     Source Type: Journal    
DOI: 10.2174/1875039701104010001     Document Type: Article

References (56)

1. Anand, P.; Sundaram, C.; Jhurani, S.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Lett., 2008, 267 (1), 133-164.
2. Kunnumakkara, A.B.; Anand, P.; Aggarwal, B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett., 2008, 269 (2), 199-225.
3. Aggarwal, B.B.; Kumar, A.; Bharti, A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res., 2003, 23 (1A), 363-398.
4. Duvoix, A.; Blasius, R.; Delhalle, S.; Schnekenburger, M.; Morceau, F.; Henry, E.; Dicato, M.; Diederich, M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett., 2005, 223 (2), 181-190.
5. Aggarwal, B.B. The past, present and future of multi-targeted cancer treatment "Naturally": Food for thought. Cancer Lett., 2008, 269 (2), 187-188.
6. Gupta, S. Prostate cancer chemoprevention: Current status and future prospects. Toxicol. Appl. Pharmacol., 2007, 224 (3), 369-376.
7. Sandur, S.K.; Pandey, M.K.; Sung, B.; Ahn, K.S.; Murakami, A.; Sethi, G.; Limtrakul, P.; Badmaev, V.; Aggarwal, B.B. Curcumin, demethoxycurcumin, bisdemothoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism. Carcinogenesis, 2007, 8 (8), 1765-1773.
8. American Cancer Society: What are the key statistics about prostate cancer, Cancer Reference Information.2008.
9. Mahudawala, D.M.; Redkar, A.A.; Wagh, A.; Gladstone, B.; Rao, K.V.K. Malignant transformation of Syrian hamster embryo (SHE) cells in culture by malachite green: An agent ofenvironmental importance. Indian J. Exp. Biol., 1999, 37 (9), 904-918.
10. Nair, H.K.; Rao, K.V.K.; Aalinkeel, R.; Mahajan, S.; Chawda, R.; Schwartz, S.A. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin. Diagn. Lab. Immunol. USA., 2004, 11 (1), 63-69.
11. Panandiker, A.; Fernandes, C.; Rao, K.V.K. The cytotoxic properties of malachite green are associated with the increased demethylase, aryl hydrocarbon hydroxylase and lipid peroxidation in primary cultures of Syrian hamster embryo cells. Cancer Lett., 1992, 67 (2-3), 93-101.
12. Panandiker, A.; Maru, G.B.; Rao, K.V.K. Dose-response effects of malachite green on free radical formation, lipid peroxidation and DNA damage in Syrian hamster embryo cells and their modulation by antioxidants. Carcinogenesis, 1994, 15 (11), 2445-2448.
13. Rao, K.V.K.; Schwartz, S.A.; Nair, H.K.; Aalinkeel, R.; Mahajan, S.; Chawda, R.; Nair, M.P.N. Plant derived products as a source of cellular growth inhibitory phytochemicals on PC-3M, DU-145 and LNCaP prostate cancer cell lines. Curr Sci., 2004, 87, 1585-1588.
14. Updike, MS.; Sawdy, J.C.; Wang, L.S.; Liu, S.; Huang, Y.W.; Ye, W.; Farrar, W.B.; Lin, Y.C.; Wick, M. Primary cultured human breast epithelial cells up-regulate protein disulfide isomerase in response to zeranol. Anticancer Res., 2007, 27, 407-10.
15. Wek, RC,; Cavener DR. Translational control and the unfolded protein response. Antioxid. Redox. Signal., 2007, 9, 2357-2371.
16. Anto, R.J.; George, J.; Babu, K.V.; Rajasekharan, K.N.; Kuttan, R. Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat. Res., 1996, 370 (2), 127-131.
17. Alpers, D.H. The potential use of curcumin in management of chronic disease: too good to be true? Curr. Opin. Gastroenterol., 2008, 24 (2), 173-175.
18. Dorai, T.; Aggarwal, B.B. Role of chemopreventive agents in cancer therapy. Cancer Lett., 2004, 215 (2), 129-140.
19. Mazumder, A.; Raghavan, K.; Weinstein, J.; Kohn, K.W.; Pommier, Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem. Pharmacol., 1995, 49 (8), 1165-1170.
20. Aggarwal, B.B.; Surh, Y.H.; Shishodia, S. In: The molecular targets and therapeutics of curcumin in health and disease. Advances in Experimental Medicine and Biology, Springer Publication, 2007, vol. 995,
21. Aggarwal, B.B.; Bhatt, I.D.; Ichikawa, H.; Ahn, K.S.; Sethi, G.; Sandur, S.; Sundaram, C.; Seeram, N.; Shishodia, S. Curcumin-Biological and Medicinal Properties, The CRC Press, Boca Raton, FL, 2006, 297-368.
22. Liu, E.; Wu, J.; Cao, W.; Zhang, J.; Liu, W.; Jiang, X.; Zhang, X. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J. Neurooncol., 2007, 85 (3), 263-270.
23. Thangapazham, R.L.; Sharma, A.; Maheshwari, R.K. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J., 2006, 8 (3), E443-449.
24. Choudhuri, P.S.T.; Das, T.; Sa, G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem., 2005, 280 (20), 20059-20068.
25. Sharma, R.A.; Euden, S.A.; Platton, S.L.; Cooke, D.N.; Shafayat, A.; Hewitt, H.R.; Marczylo, T.H.; Morgan, B.; Hemingway, D.; Plummer, S.M.; Pirmohamed, M.; Gescher, A.J.; Steward, W.P. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer. Res., 2004; 10 (20), 6847-6854.
26. Garcea, G.; Berry, D.P.; Jones, D.J.; Singh, R.; Dennison, A.R.; Farmer, P.B.; Sharma, R.A.; Steward, W.P.; Gescher, A.J. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer. Epidemiol. Biomarkers. Prev., 2005, 14 (1), 120-125.
27. Yang, F.; Lim, G.P.; Begum, A.N.; Ubeda, O.J.; Mychica, R.; Simmons, S.; Ambegaokar, S.S.; Pingping, P.; Chen, R.K.; Charles, G.G.; Sally, A.F.; Cole, G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem., 2005, 280 (7), 5892-5901.
28. Rao, K.V.K.; Schwartz, SA.; Nair, HK.; Aalinkeel, R.; Mahajan, S.; Chawda, R.; Nair, MN. Plant derived products as a source of cellular growth inhibitory phytochemicals on PC-3M, DU-145 and LNCaP prostate cancer cell lines. Curr. Sci., 2004; 87: 1585-15888.
29. Li, M.; Wang, J.; Jing, J.; Hua, H., Luo, T.; Xu, L.; Wang, R.; Liu, D.; Jiang, Y. Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70. J. Cell. Mol. Med., 2009, 13 (11-12), 4540-50.
30. Tomlinson, VA.; Newbery, HJ.; Wray, NR.; Jackson, J.; Larionov, A.; Miller, WR.; Dixon, JM.; Abbott, CM. Translation elongation factor eEF1A2 is a potential oncoprotein that is verexpressed in two-thirds of breast tumours. BMC Cancer., 2005, 5 (12):113-119.
31. Wu, H.; Zhu, H.; Liu, D.X.; Niu, T.K.; Ren, X.; Patel, R.; Hait, W.N.; Yang, J.M. Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy. Cancer Res., 2009, 69 (6), 2453-60.
32. Peebles, K.A.; Duncan, M.W.; Ruch, R.J.; Malkinson, A.M. Proteomic analysis of a neoplastic mouse lung epithelial cell line whose tumorigenicity has been abrogated by transfection with the gap junction structural gene for connexin 43, Gja1. Carcinogenesis, 2003, 24 (4), 651-657.
33. Nakamura, J.; Aoyagi, S.; Nanchi, I.; Nakatsuka, S.; Hirata, E. Shibata, S.; Fukuda, M.; Yamamoto, Y.; Fukuda, I.; Tatsumi, N.; Ueda, T.; Fujiki, F.; Nomura, M.; Nishida, S.; Shirakata, T.; Hosen, N.; Tsuboi, A.; Oka, Y.; Nezu, R.; Mori, M.; Doki, Y.; Aozasa, K.; Sugiyama, H.; Oji, Y. Over-expression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle. Int. J. Oncol., 2009, 34 (5), 1181-1189
34. Odunuga, O.O.; Longshaw, V.M.; Blatch, G.L. Hop: more than an Hsp70/Hsp90 adaptor protein. BioEssays., 2004, 26 (10), 1058-1068.
35. Neckers, L.; Lee, Y. The rules of attraction. Nature., 2003, 425 (6956), 357-358.
36. Ulatowski, L.M.; Lam, M.; Vanderburg, G.; Stallcup, M.R.; Distelhorst, C.W. Relationship between Defective Mouse Mammary Tumor Virus Envelope Glycoprotein Synthesis and GRP78 Synthesis in Glucocorticoid-treated Mouse Lymphoma Cells: Evidence for translational control of GRP78 synthesis. J. Biol. Chem., 1993, 268 (10), 7482-7488
37. Board, P.G.; Coggan, M.; Chelvanayagam, G.; Easteal, S.; Jermiin, L.S.; Schulte G.K.; Danley, D.E.; Hoth, L.R.; Griffor, M.C.; Kamath, A.V.; Rosner, M.H.; Chrunyk, B.A.; Perregaux, D.E.; Gabel, C.A.; Geoghegan, K.F.; Pandit, J. Identification, characterization, and crystal structure of the Omega class glutathione transferases. J. Biol. Chem., 2000, 275 (32), 24798-24806.
38. Kretsinger, R. H.; Tolbert, D.; Nakayama, S.; Pearson, W. In: The EF-hand, homologs and analogs. Novel calcium binding proteins. Fundamentals and clinical implication Heizmann, C.W., Eds. Springer, Heidelberg, New York, 1991, 17-37.
39. Heizmann, C. W.; Hunziker, W. Intracellular calcium-binding proteins. More sites than insights, Trends Biochem. Sci., 1991, 16 (3), 98-103.
40. Fukao, T.; Mitchell, G.A.; Song, X.Q.; Nakamura, H.; Kassovska-Bratinova, S.; Orii, K.E.; Wraith, J.E.; Besley G.; Wanders R.J.A.; Niezen-Koning, K.E.; Berry, G.T.; Palmieri M.; Kondo, N. Succinyl-CoA:3-ketoacid CoA transferase (SCOT): cloning of the human SCOT gene, tertiary structural modeling of the human SCOT monomer, and characterization of three pathogenic mutations. Genomics, 2000, 68 (2), 144-151
41. Song, X.Q.; Fukao, T.; Watanabe, H.; Shintaku, H.; Hirayama, K.; Kassovska-Bratinova, S.; Kondo, N.; Mitchell, G.A. Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency: two pathogenic mutations, V133E and C456F, in Japanese siblings. Hum. Mutat., 1998, 12 (2), 83-88.
42. De Vos, W.H.; Houben, F.; Hoebe, R.A.; Hennekam, R.; van Engelen, B.; Manders, E.M.; Ramaekers, F.C.; Broers, J.L.; Van Oostveldt, P. Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins. Biochim. Biophys. Acta, 2010, 1800 (4), 448-458.
43. Ragnauth, C.D.; Warren, D.T.; Liu, Y.; McNair, R.; Tajsic, T.; Figg, N.; Shroff, R.; Skepper, J.; Shanahan, C.M.; Prelamin, A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation, 2010, 121 (20), 2200-2210.
44. Menell, J. S.; Cesarman, G. M.; Jacovina, A. T.; McLaughlin, M. A.; Lev, E. A.; Hajjar, K. A. Annexin II and bleeding in acute promyelocytic leukemia. N. Engl. J. Med., 1999, 340 (13), 994-1004
45. Ling, Q.; Jacovina, A.T.; Deora, A.B.; Febbraio, M.; Simantov, R.; Silverstein, R. L.; Hempstead, B. L.; Mark, W.; Hajjar, K. A. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J. Clin. Investig., 2004, 113 (1), 38-48.
46. Deora, A.B.; Kreitzer, G.; Jacovina, A.T.; Hajjar, K.A. An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J. Biol. Chem., 2004, 279 (42), 43411-43418.
47. Nauseef, W.M.; McCormick, S.J.; Clark, R.A. Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J. Biol. Chem., 1995, 270 (9): 4741-4747.
48. Holaska, J.M.; Black, B.E.; Love, D.C.; Hanover, J.A.; Leszyk, J.; Paschal, B.M. Calreticulin is a receptor for nuclear export. J. Cell. Biol., 2001, 152 (1), 127-140.
49. Swaminathan, V.; Kishore, A.H.; Febitha, K.K.; Kundu, T.K. Human histone chaperone nucleophosmin enhances acetylationdependent chromatin transcription. Mol. Cell. Biol., 2005, 25 (17), 7534-7545.
50. Maggi, L.B. Jr.; Kuchenruether, M.; Dadey, D.Y.; Schwope, R.M.; Grisendi, S.; Townsend, R.R.; Pandolfi, P.P.; Weber, J.D. Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol. Cell. Biol., 2008, 28 (23), 7050-7065.
51. Sommers, C.L.; Walker-Jones, D.; Heckford, S.E.; Worland, P.; Valverius, E.; Clark, R.; McCormick, F.; Stampfer, M.; Abularach, S.; Gelmann, E.P. Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogenetransformed mammary epithelial cells. Cancer Res., 1989, 49 (15), 4258-4263.
52. Perreau, J.; Lilienbaum, A.; Vasseur, M.; Paulin, D. Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells. Gene, 1998, 62 (1): 7-16.
53. Adachi, Y.; Pavlakis, G.N.; Copeland, T.D. Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia. J. Biol. Chem., 1994, 269 (3), 2258-2262.
54. Adachi, Y.; Pavlakis, G.N.; Copeland, T.D. Identification of in vivo phosphorylation sites of SET, a nuclear phosphoprotein encoded by the translocation breakpoint in acute undifferentiated leukemia. FEBS Lett., 1994, 340 (3), 231-235.
55. Ellgaard, L.; Ruddock, L.W. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep., 2005, 6 (1), 28-32.
56. Erba, H.P.; Eddy, R.; Shows, T.; Kedes, L.; Gunning, P. Structure, chromosome location, and expression of the human gamma-actin gene: differential evolution, location, and expression of the cytoskeletal beta-and gamma-actin genes. Mol. Cell. Biol., 1988, 8 (4), 1775-1789.